SCIENTURE HOLDINGS, INC. Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31)
SCIENTURE HOLDINGS, INC. (SCNX) reported Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) of 0.75% for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-10-30.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsRiskFreeInterestRate · last filed 2014-10-30
- SCIENTURE HOLDINGS, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2014-06-30 was 0.75%.
| Period end | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 9 month |
|---|---|---|
| 2014-09-30 | 0.75% 10-Q · filed 2014-10-30 | |
| 2014-06-30 | 0.75% 10-Q · filed 2014-08-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |